BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286 AND Clinical Outcome
2 results:

  • 1. Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer.
    Kanaoka S; Okabe A; Kanesaka M; Rahmutulla B; Fukuyo M; Seki M; Hoshii T; Sato H; Imamura Y; Sakamoto S; Ichikawa T; Kaneda A
    Cancer Lett; 2024 Apr; 588():216815. PubMed ID: 38490329
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.
    Nalla AK; Williams TF; Collins CP; Rae DT; Trobridge GD
    Mol Carcinog; 2016 Nov; 55(11):1761-1771. PubMed ID: 26512949
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.